All Stories

  1. Inhalable spray-dried dry powders combining ivermectin and niclosamide to inhibit SARS-CoV-2 infection in vitro

    Article • International Journal of Pharmaceutics, February 2025, Elsevier

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  2. Repurposing ebselen as an inhalable dry powder to treat respiratory tract infections

    Article • European Journal of Pharmaceutics and Biopharmaceutics, February 2024, Elsevier

    Dr Daniel Pletzer, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  3. Neuroproteomic Analysis after SARS-CoV-2 Infection Reveals Overrepresented Neurodegeneration Pathways and Disrupted Metabolic Pathways

    Article • Biomolecules, October 2023, MDPI AG

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  4. Inhalable dry powder containing remdesivir and disulfiram: Preparation and in vitro characterization

    Article • International Journal of Pharmaceutics, October 2023, Elsevier

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  5. Spray-Dried Inhalable Microparticles Combining Remdesivir and Ebselen against SARS-CoV-2 Infection

    Article • Pharmaceutics, August 2023, MDPI AG

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  6. Health nationalism in Aotearoa New Zealand during COVID-19: problems for global health equity

    Article • Nature Medicine, July 2023, Springer Science + Business Media

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  7. Alternative options for treatment-experienced people with HIV

    Article • AIDS, June 2023, Wolters Kluwer Health

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  8. Directed Evolution of Seneca Valley Virus in Tumorsphere and Monolayer Cell Cultures of a Small-Cell Lung Cancer Model

    Article • Cancers, April 2023, MDPI AG

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  9. Incorporation of SARS-CoV-2 spike NTD to RBD protein vaccine improves immunity against viral variants

    Article • iScience, April 2023, Elsevier

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  10. Monitoring antiretroviral therapy in low and middle-income countries: current status and future considerations

    Article • AIDS, November 2022, Wolters Kluwer Health

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  11. Inhaled therapy for COVID-19: Considerations of drugs, formulations and devices

    Article • International Journal of Pharmaceutics, August 2022, Elsevier

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  12. Manipulation of Spray-Drying Conditions to Develop an Inhalable Ivermectin Dry Powder

    Article • Pharmaceutics, July 2022, MDPI AG

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  13. Characterization of the First SARS-CoV-2 Isolates from Aotearoa New Zealand as Part of a Rapid Response to the COVID-19 Pandemic

    Article • Viruses, February 2022, MDPI AG

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  14. Chikungunya Virus’ High Genomic Plasticity Enables Rapid Adaptation to Restrictive A549 Cells

    Article • Viruses, January 2022, MDPI AG

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  15. Uncoupling Molecular Testing for SARS-CoV-2 From International Supply Chains

    Article • Frontiers in Public Health, January 2022, Frontiers

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  16. Reduced and highly diverse peripheral HIV-1 reservoir in virally suppressed patients infected with non-B HIV-1 strains in Uganda

    Article • Retrovirology, January 2022, Springer Science + Business Media

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  17. Ultraviolet-C Irradiation, Heat, and Storage as Potential Methods of Inactivating SARS-CoV-2 and Bacterial Pathogens on Filtering Facepiece Respirators

    Article • Pathogens, January 2022, MDPI AG

    Dr Daniel Pletzer, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  18. Rapid Response to SARS-CoV-2 in Aotearoa New Zealand: Implementation of a Diagnostic Test and Characterization of the First COVID-19 Cases in the South Island

    Article • Viruses, November 2021, MDPI AG

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  19. High-level resistance to bictegravir and cabotegravir in subtype A- and D-infected HIV-1 patients failing raltegravir with multiple resistance mutations

    Article • Journal of Antimicrobial Chemotherapy, August 2021, Oxford University Press (OUP)

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  20. Perspective: the nose and the stomach play a critical role in the NZACE2-Pātari* (modified ACE2) drug treatment project of SARS-CoV-2 infection

    Article • Expert Review of Clinical Immunology, May 2021, Taylor & Francis

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  21. Chronic opioid use modulates human enteric microbiota and intestinal barrier integrity

    Article • Gut Microbes, January 2021, Taylor & Francis

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  22. In Vivo Emergence of a Novel Protease Inhibitor Resistance Signature in HIV-1 Matrix

    Article • mBio, December 2020, ASM Journals

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  23. Predictors of first-line antiretroviral therapy failure among adults and adolescents living with HIV/AIDS in a large prevention and treatment program in Nigeria

    Article • AIDS Research and Therapy, November 2020, Springer Science + Business Media

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  24. Nanoscale flow cytometry reveals interpatient variability in HIV protease activity that correlates with viral infectivity and identifies drug-resistant viruses

    Article • Scientific Reports, October 2020, Springer Science + Business Media

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  25. Accumulation of integrase strand transfer inhibitor resistance mutations confers high-level resistance to dolutegravir in non-B subtype HIV-1 strains from patients failing raltegravir in Uganda

    Article • Journal of Antimicrobial Chemotherapy, August 2020, Oxford University Press (OUP)

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  26. Tenth Scientific Biennial Meeting of the Australasian Virology Society—AVS10 2019

    Article • Viruses, June 2020, MDPI AG

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  27. Prior Case of Resistance on Dolutegravir Plus Lamivudine Dual Therapy

    Article • AIDS Research and Human Retroviruses, April 2020, Mary Ann Liebert Inc

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  28. Performance comparison of next generation sequencing analysis pipelines for HIV-1 drug resistance testing

    Article • Scientific Reports, January 2020, Springer Science + Business Media

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  29. In Vivo Emergence of a Novel Protease Inhibitor Resistance Signature in HIV-1 Matrix

    Article • December 2019, Cold Spring Harbor Laboratory Press

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  30. Decreased Enteric Bacterial Composition and Diversity in South American Crohn’s Disease Vary With the Choice of Treatment Strategy and Time Since Diagnosis

    Article • Journal of Crohn s and Colitis, November 2019, Oxford University Press (OUP)

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  31. HIV/AIDS in Sierra Leone: Characterizing the Hidden Epidemic

    Article • Aids Reviews, January 2019, Publicidad Permanyer, SLU

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  32. First-line HIV treatment failures in non-B subtypes and recombinants: a cross-sectional analysis of multiple populations in Uganda

    Article • AIDS Research and Therapy, January 2019, Springer Science + Business Media

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  33. Characterization of minority HIV-1 drug resistant variants in the United Kingdom following the verification of a deep sequencing-based HIV-1 genotyping and tropism assay

    Article • AIDS Research and Therapy, November 2018, Springer Science + Business Media

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  34. Absence of HIV-1 Drug Resistance Mutations Supports the Use of Dolutegravir in Uganda

    Article • AIDS Research and Human Retroviruses, May 2018, Mary Ann Liebert Inc

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  35. Emergence of Resistance to Colistin During the Treatment of Bloodstream Infection Caused by Klebsiella pneumoniae Carbapenemase–Producing Klebsiella pneumoniae

    Article • Open Forum Infectious Diseases, April 2018, Oxford University Press (OUP)

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  36. Tapering Courses of Oral Vancomycin Induce Persistent Disruption of the Microbiota That Provide Colonization Resistance to Clostridium difficile and Vancomycin-Resistant Enterococci in Mice

    Article • Antimicrobial Agents and Chemotherapy, March 2018, ASM Journals

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  37. Sensitive detection of HIV-1 resistance to Zidovudine and impact on treatment outcomes in low- to middle-income countries

    Article • Infectious Diseases of Poverty, December 2017, Springer Science + Business Media

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  38. Prion seeding activity and infectivity in skin samples from patients with sporadic Creutzfeldt-Jakob disease

    Article • Science Translational Medicine, November 2017, American Association for the Advancement of Science

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  39. HIV-1 strains belonging to large phylogenetic clusters show accelerated escape from integrase inhibitors in cell culture compared with viral isolates from singleton/small clusters

    Article • Journal of Antimicrobial Chemotherapy, May 2017, Oxford University Press (OUP)

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  40. Impaired human immunodeficiency virus type 1 replicative fitness in atypical viremic non-progressor individuals

    Article • AIDS Research and Therapy, March 2017, Springer Science + Business Media

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  41. Increased replication capacity following evolution of PYxE insertion in Gag-p6 is associated with enhanced virulence in HIV-1 subtype C from East Africa

    Article • Journal of Medical Virology, July 2016, Wiley

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  42. Novel high throughput pooled shRNA screening identifies NQO1 as a potential drug target for host directed therapy for tuberculosis

    Article • Scientific Reports, June 2016, Springer Science + Business Media

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  43. Low-Frequency Drug Resistance in HIV-Infected Ugandans on Antiretroviral Treatment Is Associated with Regimen Failure

    Article • Antimicrobial Agents and Chemotherapy, March 2016, ASM Journals

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  44. Identifying Variants in GBM: Comparison of ExomeSeq and CCP

    Article • PLOS One, May 2015, PLOS

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  45. BI-29 * VARIANT ANALYSIS OF PRIMARY AND RECURRENT GLIOBLASTOMA USING ION AMPLISEQTM COMPREHENSIVE CANCER PANEL AND WHOLE EXOME SEQUENCING

    Article • Neuro-Oncology, November 2014, Oxford University Press (OUP)

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  46. Deep sequencing: Becoming a critical tool in clinical virology

    Article • Journal of Clinical Virology, September 2014, Elsevier

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  47. Role of HIV Minority Variants in Drug Resistance

    Article • PLOS One, August 2014, PLOS

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  48. HIV-1 and GBV-C co-infection in Venezuela

    Article • The Journal of Infection in Developing Countries, July 2014, Journal of Infection in Developing Countries

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  49. The Role of Viral Genetic Variability in HIV-Associated Neurocognitive Disorder

    Article • April 2014, ASM Journals

    Pandjassarame Kangueane, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  50. Next-Generation Sequencing to Help Monitor Patients Infected with HIV: Ready for Clinical Use?

    Article • Current Infectious Disease Reports, March 2014, Springer Science + Business Media

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  51. Sensitive Deep-Sequencing-Based HIV-1 Genotyping Assay To Simultaneously Determine Susceptibility to Protease, Reverse Transcriptase, Integrase, and Maturation Inhibitors, as Well as HIV-1 Coreceptor Tropism

    Article • Antimicrobial Agents and Chemotherapy, January 2014, ASM Journals

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  52. Impact of Resistance Mutations on HIV-1 Replicative Fitness and INSTI Susceptibility

    Article • PLOS One, June 2013, PLOS

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  53. Sensitive Cell-Based Assay for Determination of Human Immunodeficiency Virus Type 1 Coreceptor Tropism

    Article • Journal of Clinical Microbiology, March 2013, ASM Journals

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu, Dr. Vicente Soriano

  54. Comparison of Four NGS Platforms for HIV-1 Coreceptor Tropism Prediction

    Article • PLOS One, November 2012, PLOS

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  55. Editorial: [Hot Topic: Use of Microbicides to Prevent HIV Sexual Transmission (Guest Editor: Miguel E. Quinones-Mateu)]

    Article • Current HIV Research, January 2012, Bentham Science Publishers

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  56. Mucosal Transmission of Human Immunodeficiency Virus

    Article • Current HIV Research, January 2012, Bentham Science Publishers

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  57. Virus-inhibitory peptide

    Article • AIDS, August 2011, Wolters Kluwer Health

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  58. Identification of low-molecular weight inhibitors of HIV-1 reverse transcriptase using a cell-based high-throughput screening system

    Article • Antiviral Research, August 2011, Elsevier

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  59. Human Immunodeficiency Virus Type 1 Resistance or Cross-Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Currently under Development as Microbicides

    Article • Antimicrobial Agents and Chemotherapy, June 2011, ASM Journals

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  60. Novel Method for Simultaneous Quantification of Phenotypic Resistance to Maturation, Protease, Reverse Transcriptase, and Integrase HIV Inhibitors Based on 3′Gag(p2/p7/p1/p6)/PR/RT/INT-Recombinant Viruses: a Useful Tool in the Multitarget Era of Antire...

    Article • Antimicrobial Agents and Chemotherapy, May 2011, ASM Journals

    Dr. Vicente Soriano, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  61. Human Immunodeficiency Virus Type 1 Resistance or Cross-Resistance to Nonnucleoside Reverse Transcriptase Inhibitors Currently under Development as Microbicides

    Article • Antimicrobial Agents and Chemotherapy, January 2011, ASM Journals

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  62. Novel Recombinant Virus Assay for Measuring Susceptibility of Human Immunodeficiency Virus Type 1 Group M Subtypes To Clinically Approved Drugs

    Article • Journal of Clinical Microbiology, April 2009, ASM Journals

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  63. Current tests to evaluate HIV-1 coreceptor tropism

    Article • Current Opinion in HIV and AIDS, March 2009, Wolters Kluwer Health

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  64. Increased Levels of Human Beta-Defensins mRNA in Sexually HIV-1 Exposed But Uninfected Individuals

    Article • Current HIV Research, November 2008, Bentham Science Publishers

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  65. Impact on Replicative Fitness of the G48E Substitution in the Protease of HIV-1

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, July 2008, Wolters Kluwer Health

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  66. Viral Drug Resistance and Fitness

    Article • January 2008, Elsevier

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  67. Viral fitness: relation to drug resistance mutations and mechanisms involved: nucleoside reverse transcriptase inhibitor mutations

    Article • Current Opinion in HIV and AIDS, March 2007, Wolters Kluwer Health

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  68. The impact of viral and host elements on HIV fitness and disease progression

    Article • Current HIV/AIDS Reports, February 2007, Springer Science + Business Media

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  69. Cystic Fibrosis and Normal Human Airway Epithelial Cell Response to Influenza A Viral Infection.

    Article • Journal of Interferon & Cytokine Research, September 2006, Mary Ann Liebert Inc

    Professor Bryan R. G. Williams, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  70. Use of a novel assay based on intact recombinant viruses expressing green (EGFP) or red (DsRed2) fluorescent proteins to examine the contribution of pol and env genes to overall HIV-1 replicative fitness

    Article • Journal of Virological Methods, September 2006, Elsevier

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  71. HIV tropism: diagnostic tools and implications for disease progression and treatment with entry inhibitors

    Article • AIDS, June 2006, Wolters Kluwer Health

    Dr. Vicente Soriano, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  72. Role of Human β-defensins in HIV Infection

    Article • Advances in Dental Research, April 2006, SAGE Publications

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  73. Virus Fitness: Concept, Quantification, and Application to HIV Population Dynamics

    Article • January 2006, Springer Science + Business Media

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  74. Persistent Replication of Human Immunodeficiency Virus Type 1 despite Treatment of Pulmonary Tuberculosis in Dually Infected Subjects

    Article • Clinical and Vaccine Immunology, November 2005, ASM Journals

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  75. Is HIV-1 evolving to a less virulent (pathogenic) virus?

    Article • AIDS, October 2005, Wolters Kluwer Health

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  76. The Replicative Fitness of Primary Human Immunodeficiency Virus Type 1 (HIV-1) Group M, HIV-1 Group O, and HIV-2 Isolates

    Article • Journal of Virology, July 2005, ASM Journals

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  77. Combination of a mutagenic agent with a reverse transcriptase inhibitor results in systematic inhibition of HIV-1 infection

    Article • Virology, July 2005, Elsevier

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  78. Diminished Replicative Fitness of Primary Human Immunodeficiency Virus Type 1 Isolates Harboring the K65R Mutation

    Article • Journal of Clinical Microbiology, March 2005, ASM Journals

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  79. HIV-1 mutagenesis during antiretroviral therapy: implications for successful drug treatment

    Article • Frontiers in Bioscience, January 2005, IMR Press

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  80. Drug Resistance, Virus Fitness and HIV-1 Mutagenesis

    Article • Current Pharmaceutical Design, December 2004, Bentham Science Publishers

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  81. Failure to Detect Human Immunodeficiency Virus Type 1 Superinfection in 28 HIV-Seroconcordant Individuals with High Risk of Reexposure to the Virus

    Article • AIDS Research and Human Retroviruses, September 2004, Mary Ann Liebert Inc

    Dr. Vicente Soriano, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  82. Fitness Variations and their Impact on the Evolution of Antiretroviral Drug Resistance

    Article • Current Drug Targets - Infectious Disorders, December 2003, Bentham Science Publishers

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  83. Human epithelial β-defensins 2 and 3 inhibit HIV-1 replication

    Article • AIDS, November 2003, Wolters Kluwer Health

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  84. Role of the Human Immunodeficiency Virus Type 1 Envelope Gene in Viral Fitness

    Article • Journal of Virology, August 2003, ASM Journals

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  85. A novel TaqMan real-time PCR assay to estimate ex vivo human immunodeficiency virus type 1 fitness in the era of multi-target (pol and env) antiretroviral therapy

    Article • Journal of General Virology, August 2003, Society for General Microbiology

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  86. Role of Baseline pol Genotype in HIV-1 Fitness Evolution

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, August 2003, Wolters Kluwer Health

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  87. Sorting out the complexities of HIV-1 fitness

    Article • AIDS, March 2003, Wolters Kluwer Health

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  88. Comparing the Ex Vivo Fitness of CCR5-Tropic Human Immunodeficiency Virus Type 1 Isolates of Subtypes B and C

    Article • Journal of Virology, January 2003, ASM Journals

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  89. Fitness of drug resistant HIV-1: methodology and clinical implications

    Article • Drug Resistance Updates, December 2002, Elsevier

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  90. Insertions in the Reverse Transcriptase Increase both Drug Resistance and Viral Fitness in a Human Immunodeficiency Virus Type 1 Isolate Harboring the Multi-Nucleoside Reverse Transcriptase Inhibitor Resistance 69 Insertion Complex Mutation

    Article • Journal of Virology, October 2002, ASM Journals

    Antonio Mas, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  91. In Vitro Intersubtype Recombinants of Human Immunodeficiency Virus Type 1: Comparison to Recent and Circulating In Vivo Recombinant Forms

    Article • Journal of Virology, October 2002, ASM Journals

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  92. Human Immunodeficiency Virus Type 1 (HIV-1)Quasispecies at the Sites of Mycobacterium tuberculosis InfectionContribute to Systemic HIV-1 Heterogeneity

    Article • Journal of Virology, February 2002, ASM Journals

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  93. Mechanisms Involved in Stimulation of Human Immunodeficiency Virus Type 1 Replication by Aminooxypentane RANTES

    Article • Journal of Virology, September 2001, ASM Journals

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  94. Functional Characterization of Chimeric Reverse Transcriptases with Polypeptide Subunits of Highly Divergent HIV-1 Group M and O Strains

    Article • Journal of Biological Chemistry, May 2001, American Society for Biochemistry & Molecular Biology (ASBMB)

    Antonio Mas, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  95. A Dual Infection/Competition Assay Shows a Correlation between Ex Vivo Human Immunodeficiency Virus Type 1 Fitness and Disease Progression

    Article • Journal of Virology, October 2000, ASM Journals

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu, Prof Robert Colebunders

  96. Greater Diversity of HIV-1 Quasispecies in HIV-Infected Individuals With Active Tuberculosis

    Article • JAIDS Journal of Acquired Immune Deficiency Syndromes, August 2000, Wolters Kluwer Health

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  97. Variable Sensitivity of CCR5-Tropic Human Immunodeficiency Virus Type 1 Isolates to Inhibition by RANTES Analogs

    Article • Journal of Virology, May 2000, ASM Journals

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  98. Phylogeny of HIV Type 1 Group O Isolates Based on env Gene Sequences

    Article • AIDS Research and Human Retroviruses, May 1999, Mary Ann Liebert Inc

    Antonio Mas, Dr. Vicente Soriano, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  99. Molecular Epidemiology of HIV Type 1 Isolates from the Czech Republic: Identification of an env E Subtype Case

    Article • AIDS Research and Human Retroviruses, January 1999, Mary Ann Liebert Inc

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  100. Nucleotide Diversity in Three Different Genomic Regions of Venezuelan HIV Type 1 Isolates: A Subtyping Update

    Article • AIDS Research and Human Retroviruses, January 1999, Mary Ann Liebert Inc

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  101. Analysis of pol Gene Heterogeneity, Viral Quasispecies, and Drug Resistance in Individuals Infected with Group O Strains of Human Immunodeficiency Virus Type 1

    Article • Journal of Virology, November 1998, ASM Journals

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu, Dr. Vicente Soriano

  102. LTR and tat variability of HIV-1 isolates from patients with divergent rates of disease progression

    Article • Virus Research, September 1998, Elsevier

    Antonio Mas, Dr. Vicente Soriano, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  103. 3′-Azido-3′-Deoxythymidine (AZT) Mediates Cross-Resistance to Nucleoside Analogs in the Case of AZT-Resistant Human Immunodeficiency Virus Type 1 Variants

    Article • Journal of Virology, June 1998, ASM Journals

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  104. Mechanisms of clinical resistance by HIV-I variants to zidovudine and the paradox of reverse transcriptase sensitivity

    Article • Drug Resistance Updates, March 1998, Elsevier

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  105. Characterization of the Reverse Transcriptase of a Human Immunodeficiency Virus Type 1 Group O Isolate

    Article • Virology, September 1997, Elsevier

    Dr. Vicente Soriano, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  106. Viral quasispecies and the problem of vaccine-escape and drug-resistant mutants

    Article • January 1997, Springer Science + Business Media

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  107. Sequence Note : env Gene Characterization of the First HIV Type 1 Group O Spanish Isolate

    Article • AIDS Research and Human Retroviruses, November 1996, Mary Ann Liebert Inc

    Antonio Mas, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  108. Point Mutant Frequencies in thepolGene of Human Immunodeficiency Virus Type 1 Are Two- to Threefold Lower Than Those ofenv

    Article • AIDS Research and Human Retroviruses, August 1996, Mary Ann Liebert Inc

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  109. Activation of antigen-induced lymphocyte proliferation by interleukin-15 without the mitogenic effect of interleukin-2 that may induce human immunodeficiency virus-1 expression.

    Article • Journal of Clinical Investigation, August 1996, American Society for Clinical Investigation

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  110. Sequence Note: env Gene Diversity of HIV Type 1 Isolates from Spain

    Article • AIDS Research and Human Retroviruses, July 1996, Mary Ann Liebert Inc

    Dr. Vicente Soriano, Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  111. Molecular Characterization of Human Immunodeficiency Virus Type 1 Isolates from Venezuela

    Article • AIDS Research and Human Retroviruses, May 1995, Mary Ann Liebert Inc

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  112. Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy

    Article • Journal of Virology, January 1995, ASM Journals

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  113. Muscular Changes in Venezuelan Wild Horses Naturally Infected with Trypanosoma evansi

    Article • Journal of Comparative Pathology, January 1994, Elsevier

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu

  114. Seroprevalence of retroviruses in the Amazonian rainforest

    Article • AIDS, July 1993, Wolters Kluwer Health

    Western Research Chair in Viral Pathogenesis Miguel Quinones-Mateu